Annual Activities Report 2011 - INCT-Inofar - UFRJ

More documents

Recommendations

Info

Annual Report 2011 | INCT-INOFAR 68 INCT-INOFAR in the Media Through its Media Secretary, INCT-INOFAR publicizes its research in the media. Two INCT-INOFAR incremental innovation projects, in the field of generic drugs, had great repercussion in the Brazilian and foreign media during 2011.
Annual Report 2011 | INCT-INOFAR 69 New synthetic route for atorvastatin – In December 2010, the same month where the Lipitor ®/ Pfizer patent expired in Brazil, INCT- INOFAR researchers announced the discovery of a new synthetic route for the production of its active principle, atorvastatin. A continuous use medication for cholesterol reduction of wide use, Lipitor® is the number one sold pharmaceutical in the world. INCT-INOFAR produced a hot site to make the media clipping on the discovery available. Interviews with the researchers responsible for the discovery, Prof. Luiz Carlos Dias and Dr. Adriano Siqueira Vieira of the Institute of Chemistry of the State University of Campinas (UNICAMP) on the radio, TV, newspapers, magazines and websites in Brazil and abroad are available. www.portaldosfarmacos.ccs.ufrj.br/inct/hot_atorvastatina/main.swf At the atorvastatin hot site, all it takes is a click on the headlines to read the articles. New synthetic route for Sunitinib – Recommended to fight certain types of cancers on the kidneys, stomach, and intestines, Sunitinib is the active principle of Sutent®/ Pfizer, a high price medication – around 11 thousand Reais for a box with 28 pills - that, unfortunately, is not made available in the public health care system (SUS), and which is the target of several lawsuits because of this. The new synthetic route for Sunitinib was developed by Prof. Angelo da Cunha Pinto, and by Prof. Barbara Vasconcellos da Silva, of the Institute of Chemistry of the Federal University of Rio de Janeiro (UFRJ). After the news was publicized in academic journals, in late September 2011, the Terra Portal in Spain also reported on the discovery. 09/28/2011 Science Journal: High cost medication may have cheaper generic 09/29/2011 FAPERJ Journal: Researchers develop process to produce generic chemotherapeutical 09/29/2011 Portal Terra: Tecnología brasileña reduce costo de medicina contra el cáncer 10/04/2011 iSaúde! Portal: Process developed in Brazil allows for production of generic chemotherapeutical 10/13/2011 Vital Look / UFRJ: Institute of Chemistry researchers develop generic pharmaceutical to fight certain types of cancer
Page 1 and 2:
Annual Report 2011 | INCT-INOFAR 1
Page 3 and 4:
2011 ANNUAL ACTIVITIES REPORT Drugs
Page 5 and 6:
Page 7 and 8:
Page 9 and 10:
Page 11 and 12:
Page 13 and 14:
Page 15 and 16:
Page 17 and 18: Annual Report 2011 | INCT-INOFAR 17
Page 55 and 56: Annual Report 2011 | INCT-INOFAR Hi
Page 67: Annual Report 2011 | INCT-INOFAR 67
Page 119 and 120:
Page 121 and 122:
Page 123 and 124:
Page 125 and 126:
Page 127 and 128:
show all

Annual Activities Report 2011 - INCT-Inofar - UFRJ

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?